Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size

被引:493
作者
Stier, S
Ko, Y [1 ]
Forkert, F
Lutz, C
Neuhaus, T
Grünewald, E
Cheng, T
Dombkowski, D
Calvi, LM
Rittling, SR
Scadden, DT
机构
[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Canc Ctr,Ctr Regenerat Med & Technol, Boston, MA 02114 USA
[2] Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA
[3] Univ Bonn, Med Poliklin, D-53111 Bonn, Germany
[4] Univ Rochester, Sch Med, Dept Med, Rochester, NY 14642 USA
[5] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA
关键词
D O I
10.1084/jem.20041992
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Stem cells reside in a specialized niche that regulates their abundance and fate. Components of the niche have generally been defined in terms of cells and signaling pathways. We define a role for a matrix glycoprotein, osteopontin (OPN), as a constraining factor on hematopoietic stem cells within the bone marrow microenvironment. Osteoblasts that participate in the niche produce varying amounts of OPN in response to stimulation. Using studies that combine OPN-deficient mice and exogenous OPN, we demonstrate that OPN modifies primitive hematopoietic cell number and function in a stem cell-nonautonomous manner. The OPN-null microenvironment was sufficient to increase the number of stem cells associated with increased stromal Jagged1 and Angiopoietin-1 expression and reduced primitive hematopoietic cell apoptosis. The activation of the stem cell microenvironment with parathyroid hormone induced a superphysiologic increase in stem cells in the absence of OPN. Therefore, OPN is a negative regulatory element of the stem cell niche that limits the size of the stem cell pool and may provide a mechanism for restricting excess stem cell expansion under conditions of niche stimulation.
引用
收藏
页码:1781 / 1791
页数:11
相关论文
共 50 条
[1]  
ANTICA M, 1994, BLOOD, V84, P111
[2]   Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche [J].
Arai, F ;
Hirao, A ;
Ohmura, M ;
Sato, H ;
Matsuoka, S ;
Takubo, K ;
Ito, K ;
Koh, GY ;
Suda, T .
CELL, 2004, 118 (02) :149-161
[3]   Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity [J].
Ashkar, S ;
Weber, GF ;
Panoutsakopoulou, V ;
Sanchirico, ME ;
Jansson, M ;
Zawaideh, S ;
Rittling, SR ;
Denhardt, DT ;
Glimcher, MJ ;
Cantor, H .
SCIENCE, 2000, 287 (5454) :860-864
[4]  
Bayless KJ, 1998, J CELL SCI, V111, P1165
[5]   Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone [J].
Calvi, LM ;
Sims, NA ;
Hunzelman, JL ;
Knight, MC ;
Giovannetti, A ;
Saxton, JM ;
Kronenberg, HM ;
Baron, R ;
Schipani, E .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (03) :277-286
[6]   Osteoblastic cells regulate the haematopoietic stem cell niche [J].
Calvi, LM ;
Adams, GB ;
Weibrecht, KW ;
Weber, JM ;
Olson, DP ;
Knight, MC ;
Martin, RP ;
Schipani, E ;
Divieti, P ;
Bringhurst, FR ;
Milner, LA ;
Kronenberg, HM ;
Scadden, DT .
NATURE, 2003, 425 (6960) :841-846
[7]   ACUTE EFFECTS OF HIGH-DOSE CHEMOTHERAPY FOLLOWED BY BONE-MARROW TRANSPLANTATION ON SERUM MARKERS OF BONE METABOLISM [J].
CARLSON, K ;
SIMONSSON, B ;
LJUNGHALL, S .
CALCIFIED TISSUE INTERNATIONAL, 1994, 55 (06) :408-411
[8]   The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease [J].
Chabas, D ;
Baranzini, SE ;
Mitchell, D ;
Bernard, CCA ;
Rittling, SR ;
Denhardt, DT ;
Sobel, RA ;
Lock, C ;
Karpuj, M ;
Pedotti, R ;
Heller, R ;
Oksenberg, JR ;
Steinman, L .
SCIENCE, 2001, 294 (5547) :1731-1735
[9]   Osteopontin expression in lung cancer [J].
Chambers, AF ;
Wilson, SM ;
Kerkvliet, N ;
OMalley, FP ;
Harris, JF ;
Casson, AG .
LUNG CANCER, 1996, 15 (03) :311-323
[10]  
CHEN SC, 2000, KLUW INT S ADV DATA, V21, P1